New N-myristoyltransferase inhibitors presented by MyricX Pharma, Imperial Innovations Group April 12, 2022
Cocktail of two human survivor antibodies protects NHPs from Ebola and Sudan virus diseases April 12, 2022
ADAM17 inhibition alleviates COVID-19-associated cytokine storm in lung epithelial cells April 11, 2022